CVRdatabase
Menu

MedTrace Pharma A/S

Public limited companyCVR 36497661HørsholmActive

MedTrace Pharma A/S is a public limited company, based in Hørsholm, active in renting and leasing of other machinery, equipment and tangible goods for events, founded in 2015. The company made a loss in both 2024 and 2025, most recently DKK 35.1m. With 32 employees, the company is about 11 times larger than the industry median. 8 other companies in the database are registered at the same address.

Follow
PDF reportCompare

Key figures · financial year 2025

RevenueDKK 1.8m−24.6% vs. 2024
Net profit−DKK 35.1m−128.8% vs. 2024
EquityDKK 302.6m+12.1% vs. 2024
Employees32latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit fell 228% (2024 → 2025), to −DKK 302k.
  • Revenue fell 25% (2024 → 2025), to DKK 1.8m.
  • The loss grew: from DKK 15.4m to DKK 35.1m (2024 → 2025).
  • Equity rose 12% (2024 → 2025), to DKK 302.6m.

Employees

  • 4 more employees than a year earlier: 32 (07/2026) against 28 (07/2025).

Management and owners, last 24 months

  • New in management: Lykke Jul Rømer (director, 12/06/2025), Peter Juul Kristensen (ceo, 01/11/2025) and Charlotte Vindfeldt (board member, 01/11/2025) (+1).
  • Stepped down: Robert Karl Schier (board member, 31/12/2025), Peter Juul Kristensen (board member, 31/10/2025) and Lars Trolle (director, 01/05/2025) (+1).
  • New owners registered: Fund Investments S.A. SICAV-RAIF - Verve Venture Fund I (21/05/2025), Arbejdsmarkedets Tillægspension (14/04/2026) and MedTravest IV ApS (14/04/2026) (+2).
  • No longer registered as owner: EIC Fund (10/10/2025), Arbejdsmarkedets Tillægspension (13/04/2026) and Fonden for Syddansk Vækstfremme (21/05/2025) (+3).

Registrations, last 24 months

  • 14/04/2026: Share capital changed from 12,034,994 DKK to 16,093,364 DKK
  • 02/02/2026: Share capital changed from 12,034,169 DKK to 12,034,994 DKK
  • 04/12/2025: Share capital changed from 11,178,914 DKK to 12,034,169 DKK
  • 10/10/2025: Share capital changed from 10,824,437 DKK to 11,178,914 DKK
  • 29/08/2025: Share capital changed from 9,556,471 DKK to 10,824,437 DKK
  • 21/05/2025: Share capital changed from 7,164,318 DKK to 9,556,471 DKK

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

−DKK 50mDKK 0DKK 50mDKK 100mDKK 150mDKK 200mDKK 250mDKK 300m202020212022202320242025
EquityNet profit
Financial figures for MedTrace Pharma A/S
202020212022202320242025Change
Revenuenot stated1,5292,1932,6452,3341,759−24.6%
Gross profit3,0123741,9232,039236−302−228%
Operating profit (EBIT)1,824−24,475−49,052−20,072−23,515−25,891−10.1%
Profit before tax862−24,878−49,955−18,157−20,806−25,932−24.6%
Net profit1,244−17,852−37,035−15,107−15,356−35,131−128.8%
Total assets58,520119,516190,685307,595289,595337,095+16.4%
Equity34,61793,707161,191285,237270,065302,614+12.1%
Liabilities17,10225,80929,49422,35819,53034,481+76.6%
Cash and cash equivalents14,01538,33369,446122,31734,31723,564−31.3%
Average number of employees5––––––

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

−DKK 500kDKK 0DKK 500kDKK 1mDKK 1.5mDKK 2mDKK 2.5mDKK 3m202020212022202320242025
Gross profitMedian, the industry (105 companies)

Signals from the financial statements

calculated from the 2025 figures

  • Loss for 5 years in a row

    Net result has been negative in 2021–2025.

    How is this calculated?

    Net result is negative in the two or more latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for MedTrace Pharma A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202513/05/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202428/05/2025The companyPDF not statedXBRL
202301/01/2023 – 31/12/202317/05/2024The companyPDF not statedXBRL
202201/01/2022 – 31/12/202212/06/2023The companyPDF not statedXBRL
202101/01/2021 – 31/12/202116/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202010/06/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0510152025303508/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

105 companies in the database

Comparison with the other companies in renting and leasing of other machinery, equipment and tangible goods for events based on the latest financial year.

Gross profit−DKK 302kNo. 103 of 105
Better than 2% of the companies in the industry
EquityDKK 302.6mNo. 1 of 105
Better than 100% of the companies in the industry
Number of employees32No. 7 of 105
Better than 94% of the companies in the industry

Industry median: gross profit DKK 2.8m, net profit DKK 311k, equity DKK 2.8m, 3 employees.

DKK 100kDKK 773kDKK 6mDKK 46.1mDKK 180.2m
Distribution of gross profit for 95 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with 20–49 employees9,922 companies in the comparison
No. 9,747of 9,892
Better than 1%
No. 145of 9,922
Better than 99%
Same industry and 20–49 employees12 companies in the comparison
No. 12of 12
Better than 0%
No. 1of 12
Better than 100%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 32,699of 33,588
Better than 3%
No. 286of 33,687
Better than 99%
All companies of type A/S18,025 companies in the comparison
No. 17,093of 17,786
Better than 4%
No. 1,049of 18,024
Better than 94%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Renting and leasing of other machinery, equipment and tangible goods for events
Gross profit
  1. MedTrace Pharma A/S−DKK 302k
  2. H.j. Hansen Holding A/SDKK 356.2m
  3. Godik ApSDKK 123.4m
Net profit
  1. MedTrace Pharma A/S−DKK 35.1m
  2. H.j. Hansen Holding A/SDKK 31.2m
  3. Godik ApSDKK 4.9m
Equity
  1. MedTrace Pharma A/SDKK 302.6m
  2. H.j. Hansen Holding A/SDKK 298.4m
  3. Godik ApSDKK 269.8m
Employees
  1. MedTrace Pharma A/S32
  2. H.j. Hansen Holding A/S2
  3. Godik ApS127

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Swisscanto Private Equity I KmGK10%
  • Fund Investments S.A. SICAV-RAIF - Verve Venture Fund I5%
  • Arbejdsmarkedets Tillægspension33.33%
  • MedTravest IV ApS15%
MedTrace Pharma A/S

Management

8 active registrations

Executive management

Executive management at MedTrace Pharma A/S
NameRoleAppointed
Lykke Jul RømerDirector12/06/2025
Peter Juul KristensenCEO01/11/2025

Board of directors

Board of directors at MedTrace Pharma A/S
NameRoleAppointed
Jens Hesthaven SørensenBoard member12/07/2018
Cesare OrlandiBoard member22/10/2020
Claus Henrik Berner MøllerBoard member01/01/2024
Erik Anders StrömqvistChair of the board01/01/2024
Charlotte VindfeldtBoard member01/11/2025
Ellen Rietmann AhlBoard member01/01/2026
Auditor
KPMG P/S
Founders
Martin Dal Stenfeldt, Scansys Holding ApS, Wiik Invest ApS
Former management (21)
Former management at MedTrace Pharma A/S
NameRoleAppointedResigned
Martin Dal StenfeldtCEO05/01/201519/12/2022
Peter LarsenDirector05/01/201505/10/2015
Rune Wiik KristensenDirector05/01/201505/10/2015
Bjarne Henning JensenChair of the board05/10/201520/04/2017
Mads Spangaard RasmussenBoard member05/10/201511/09/2023
Bernt Skov JensenBoard member05/10/201511/05/2021
Lenna Maria Boe BrobergBoard member04/08/201629/01/2018
Ulrik SporkChair of the board20/04/201711/05/2021
Michael FrankBoard member29/01/201811/05/2021
Erik Anders StrömqvistBoard member22/10/202010/05/2021
Claus Henrik Berner MøllerBoard member11/05/202113/12/2022
Rune Wiik KristensenDirector11/05/202101/01/2024
Erik Anders StrömqvistChair of the board11/05/202113/12/2022
Robert Karl SchierBoard member11/05/202131/12/2025
Ann Kristin Brøgger LedDirector01/04/202231/12/2023
Claus Henrik Berner MøllerChair of the board14/12/202231/12/2023
Erik Anders StrömqvistCEO14/12/202201/01/2024
Erik Anders StrömqvistBoard member14/12/202231/12/2023
Peter Juul KristensenBoard member04/12/202331/10/2025
Lars TrolleDirector01/01/202401/05/2025
Ann Kristin Brøgger LedCEO01/01/202412/06/2025

Signing rule: Selskabet tegnes af to medlemmer af direktionen i forening, bestyrelsesformanden i forening med én direktør, eller af den samlede bestyrelse.

Address and production units

1 active production units

Agern Alle 5A
2970 Hørsholm

Rudersdal Municipality · Postcode 2970

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
MedTrace Pharma A/SAgern Alle 5A, 2970 Hørsholm301027752574

Purpose

Selskabets formål er at udvikle, kommercialisere og sælge et automatisk injektionssystem til radioaktivt vand.

The purpose is quoted from the register in Danish.

Changes year by year

162 registered events
20269 changesaccounts 1 · capital 2 · ownership 5 · management 1
  • Annual report for 2025 published
  • Share capital changed from 12,034,994 DKK to 16,093,364 DKK
  • Arbejdsmarkedets Tillægspension registered as owner (33.33%)
  • MedTravest IV ApS registered as owner (15%)
  • Kapitalforeningen BankInvest Select is no longer registered as owner
  • MedTravest IV ApS is no longer registered as owner
  • Arbejdsmarkedets Tillægspension is no longer registered as owner
  • Share capital changed from 12,034,169 DKK to 12,034,994 DKK
  • Ellen Rietmann Ahl appointed board member
202521 changesmanagement 7 · capital 6 · ownership 6 · accounts 1 · industry 1
  • Robert Karl Schier stepped down as board member
  • Share capital changed from 11,178,914 DKK to 12,034,169 DKK
  • Charlotte Vindfeldt appointed board member
  • Peter Juul Kristensen appointed ceo
  • Peter Juul Kristensen stepped down as board member
  • Share capital changed from 10,824,437 DKK to 11,178,914 DKK
  • EIC Fund is no longer registered as owner
  • Share capital changed from 9,556,471 DKK to 10,824,437 DKK
  • Lykke Jul Rømer appointed director
  • Ann Kristin Brøgger Led stepped down as ceo
  • Annual report for 2024 published
  • Share capital changed from 7,164,318 DKK to 9,556,471 DKK
  • MedTravest IV ApS registered as owner (10%)
  • Kapitalforeningen BankInvest Select registered as owner (5%)
  • Fund Investments S.A. SICAV-RAIF - Verve Venture Fund I registered as owner (5%)
  • FONDEN FOR SYDDANSK VÆKSTFREMME is no longer registered as owner
  • MedTravest IV ApS is no longer registered as owner
  • Lars Trolle stepped down as director
  • Share capital changed from 5,006,294 DKK to 7,164,318 DKK
  • Share capital changed from 5,000,656 DKK to 5,006,294 DKK
  • Industry changed to Renting and leasing of other machinery, equipment and tangible goods for events (773910)
20249 changescapital 2 · accounts 1 · management 6
  • Share capital changed from 4,997,341 DKK to 5,000,656 DKK
  • Annual report for 2023 published
  • Share capital changed from 4,996,833 DKK to 4,997,341 DKK
  • Lars Trolle appointed director
  • Erik Anders Strömqvist appointed chair of the board
  • Claus Henrik Berner Møller appointed board member
  • Ann Kristin Brøgger Led appointed ceo
  • Erik Anders Strömqvist stepped down as ceo
  • Rune Wiik Kristensen stepped down as director
202325 changesmanagement 5 · capital 6 · ownership 12 · industry 1 · accounts 1
  • Erik Anders Strömqvist stepped down as board member
  • Claus Henrik Berner Møller stepped down as chair of the board
  • Ann Kristin Brøgger Led stepped down as director
  • Peter Juul Kristensen appointed board member
  • Share capital changed from 4,543,463 DKK to 4,996,833 DKK
  • Share capital changed from 4,286,267 DKK to 4,543,463 DKK
  • Share capital changed from 2,717,514 DKK to 4,286,267 DKK
  • Arbejdsmarkedets Tillægspension registered as owner (25%)
  • Swisscanto Private Equity I KmGK registered as owner (10%)
  • MedTravest IV ApS registered as owner (5%)
  • FONDEN FOR SYDDANSK VÆKSTFREMME registered as owner (5%)
  • WASABI-LINK Holding ApS is no longer registered as owner
  • Uddannelses- og Forskningsstyrelsen is no longer registered as owner
  • SCANSYS HOLDING ApS is no longer registered as owner
  • WIIK INVEST ApS is no longer registered as owner
  • MedTravest A/S is no longer registered as owner
  • FONDEN FOR SYDDANSK VÆKSTFREMME is no longer registered as owner
  • Swisscanto Private Equity I KmGK is no longer registered as owner
  • Arbejdsmarkedets Tillægspension is no longer registered as owner
  • Mads Spangaard Rasmussen stepped down as board member
  • Share capital changed from 2,716,975 DKK to 2,717,514 DKK
  • Share capital changed from 2,716,684 DKK to 2,716,975 DKK
  • Industry changed to Udlejning og leasing af andet materiel, udstyr og andre materielle aktiver i.a.n. (773900)
  • Annual report for 2022 published
  • Share capital changed from 2,716,078 DKK to 2,716,684 DKK
202211 changesmanagement 7 · accounts 1 · capital 1 · address 1 · industry 1
  • Martin Dal Stenfeldt stepped down as ceo
  • Erik Anders Strömqvist appointed ceo
  • Erik Anders Strömqvist appointed board member
  • Claus Henrik Berner Møller appointed chair of the board
  • Erik Anders Strömqvist stepped down as chair of the board
  • Claus Henrik Berner Møller stepped down as board member
  • Annual report for 2021 published
  • Share capital changed from 2,010,487 DKK to 2,716,078 DKK
  • Ann Kristin Brøgger Led appointed director
  • Moved to Agern Alle 5A, 2970 Hørsholm
  • Industry changed to Manufacture of irradiation, electromedical and electrotherapeutic equipment (266090)
202120 changescapital 2 · ownership 9 · accounts 1 · management 8
  • Share capital changed from 1,876,975 DKK to 2,010,487 DKK
  • EIC Fund registered as owner (5%)
  • Annual report for 2020 published
  • Share capital changed from 1,354,053 DKK to 1,876,975 DKK
  • Robert Karl Schier appointed board member
  • Erik Anders Strömqvist appointed chair of the board
  • Rune Wiik Kristensen appointed director
  • Claus Henrik Berner Møller appointed board member
  • Michael Frank stepped down as board member
  • Ulrik Spork stepped down as chair of the board
  • Bernt Skov Jensen stepped down as board member
  • FONDEN FOR SYDDANSK VÆKSTFREMME registered as owner (10%)
  • Swisscanto Private Equity I KmGK registered as owner (5%)
  • WASABI-LINK Holding ApS registered as owner (5%)
  • Uddannelses- og Forskningsstyrelsen registered as owner (5%)
  • Arbejdsmarkedets Tillægspension registered as owner (10%)
  • Erik Anders Strömqvist stepped down as board member
  • Uddannelses- og Forskningsstyrelsen is no longer registered as owner
  • WASABI-LINK Holding ApS is no longer registered as owner
  • FONDEN FOR SYDDANSK VÆKSTFREMME is no longer registered as owner
202014 changescapital 4 · management 2 · ownership 8
  • Share capital changed from 1,346,365 DKK to 1,354,053 DKK
  • Cesare Orlandi appointed board member
  • Erik Anders Strömqvist appointed board member
  • Share capital changed from 1,309,310 DKK to 1,346,365 DKK
  • Share capital changed from 1,296,497 DKK to 1,309,310 DKK
  • Share capital changed from 1,014,893 DKK to 1,296,497 DKK
  • Uddannelses- og Forskningsstyrelsen registered as owner (10%)
  • SCANSYS HOLDING ApS registered as owner (5%)
  • WIIK INVEST ApS registered as owner (5%)
  • WASABI-LINK Holding ApS registered as owner (5%)
  • Uddannelses- og Forskningsstyrelsen is no longer registered as owner
  • WASABI-LINK Holding ApS is no longer registered as owner
  • SCANSYS HOLDING ApS is no longer registered as owner
  • WIIK INVEST ApS is no longer registered as owner
20191 changeaddress 1
  • Moved to Diplomvej 381, 2800 Kongens Lyngby
201819 changesname 1 · capital 3 · management 3 · ownership 11 · merger 1
  • Name changed from MedTrace A/S to MedTrace Pharma A/S
  • Share capital changed from 1,014,643 DKK to 1,014,893 DKK
  • Share capital changed from 826,699 DKK to 1,014,643 DKK
  • Jens Hesthaven Sørensen appointed board member
  • Uddannelses- og Forskningsstyrelsen registered as owner (15%)
  • Merger registered in CVR
  • Uddannelses- og Forskningsstyrelsen is no longer registered as owner
  • Michael Frank appointed board member
  • Lenna Maria Boe Broberg stepped down as board member
  • Share capital changed from 701,209 DKK to 826,699 DKK
  • MedTravest A/S registered as owner (5%)
  • WASABI-LINK Holding ApS registered as owner (10%)
  • SCANSYS HOLDING ApS registered as owner (10%)
  • WIIK INVEST ApS registered as owner (10%)
  • FONDEN FOR SYDDANSK VÆKSTFREMME registered as owner (15%)
  • WASABI-LINK Holding ApS is no longer registered as owner
  • WIIK INVEST ApS is no longer registered as owner
  • FONDEN FOR SYDDANSK VÆKSTFREMME is no longer registered as owner
  • SCANSYS HOLDING ApS is no longer registered as owner
20175 changesmanagement 2 · capital 1 · ownership 2
  • Ulrik Spork appointed chair of the board
  • Bjarne Henning Jensen stepped down as chair of the board
  • Share capital changed from 640,028 DKK to 701,209 DKK
  • Uddannelses- og Forskningsstyrelsen registered as owner (20%)
  • Styrelsen for Forskning og Uddannelse is no longer registered as owner
20162 changesmanagement 1 · address 1
  • Lenna Maria Boe Broberg appointed board member
  • Moved to Gotlandsvej 5, Tved, 5700 Svendborg
201526 changesname 2 · capital 2 · management 8 · ownership 13 · founded 1
  • Name changed from Medtrace ApS to MedTrace A/S
  • Share capital changed from 160,007 DKK to 640,028 DKK
  • Name changed from LSW MEDICAL IVS to Medtrace ApS
  • Share capital changed from 3 DKK to 160,007 DKK
  • Bernt Skov Jensen appointed board member
  • Mads Spangaard Rasmussen appointed board member
  • Bjarne Henning Jensen appointed chair of the board
  • Peter Larsen stepped down as director
  • Rune Wiik Kristensen stepped down as director
  • Styrelsen for Forskning og Uddannelse registered as owner (20%)
  • WASABI-LINK Holding ApS registered as owner (15%)
  • WIIK INVEST ApS registered as owner (15%)
  • FONDEN FOR SYDDANSK VÆKSTFREMME registered as owner (25%)
  • SCANSYS HOLDING ApS registered as owner (15%)
  • WASABI-LINK Holding ApS is no longer registered as owner
  • WIIK INVEST ApS is no longer registered as owner
  • SCANSYS HOLDING ApS is no longer registered as owner
  • WASABI-LINK Holding ApS registered as owner (33.33%)
  • Martin Dal Stenfeldt is no longer registered as owner
  • Registered as LSW MEDICAL IVS
  • Peter Larsen appointed director
  • Martin Dal Stenfeldt appointed ceo
  • Rune Wiik Kristensen appointed director
  • WIIK INVEST ApS registered as owner (33.33%)
  • Martin Dal Stenfeldt registered as owner (33.33%)
  • SCANSYS HOLDING ApS registered as owner (33.33%)

Related companies

Same industry in Rudersdal

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction